J.ophthalmol.(Ukraine).2020;5:36-42.
http://doi.org/10.31288/oftalmolzh202053642
Received: 27 July 2020; Published on-line: 27 October 2020
A novel concept of differences in pathogenetic mechanism of diabetic retinopathy progression between type 2 diabetes mellitus patients differing in the PPARγ genotype
L. V. Natrus1, S. Yu. Mogilevskyy2, T. I. Panova1, S. O. Rykov2, M. Iu. Bykhovets2
1 Bohomolets National Medical University;
2 Shupik National Medical Academy of Postgraduate Education;
Kyiv (Ukraine)
E-mail: Lnatrus777@gmail.com
TO CITE THIS ARTICLE: Natrus LV, Mogilevskyy SYu, Panova TI, Rykov SO, Bykhovets MIu. A novel concept of differences in pathogenetic mechanism of diabetic retinopathy progression between type 2 diabetes mellitus patients differing in the PPARγ genotype. J.ophthalmol.(Ukraine).2020;5:36-42. http://doi.org/10.31288/oftalmolzh202053642
Background: It is important to study cellular circulation of L-FABP-associated fatty acids (FA) and their oxidation through the classical pathway with activation of the PPARγ gene and under conditions of impaired lipid metabolism.
Purpose: To investigate the pathogenetic mechanisms of diabetic retinopathy (DR) progression in type 2 diabetes mellitus (T2DM) patients differing in the PPARγ genotype.
Material and Methods: This study involved 101 T2DM patients (101 eyes) with different stages of diabetic retinopathy (DR) as assessed by the ETDRS scale and 40 non-diabetics (controls) who were comparable in age, gender and body mass index. The polymorphism was detected by real-time PCR on a Real-Time Gene Amp® PCR System 7500 (Applied Biosystems). ELISA was used to determine serum L-FABP levels with Human L-FABP ELISA kit (Hycult Biotech).
Results: Our findings allowed for developing a concept of differences in pathogenetic mechanisms of DR progression between patients differing in the PPARγ genotype. Among carriers of the wild-type PPARγ genotype, DR as a complication of diabetes develops as a result of chronic inflammation and through PPARγ-dependent gene transcription, expression of the enzymes that oxidize arachidonic acid, and synthesis of the metabolites affecting the endothelium, platelets, the blood clotting system, etc. In diabetic PPARγ polymorphism carriers, PPARγ-dependent gene transcription is inhibited, and fatty acids are utilized in the cell via other L-FABP mechanisms, which results in activation of direct peroxisomal oxidation and increased oxidative stress-induced inflammation.
A new insight into differences in pathogenetic mechanisms of DR progression between T2DM patients differing in the PPARγ genotype provides the basis for subsequent clinical development of advanced, customized management schemes for patients with different DR stages to prevent further retinal damage.
Keywords: diabetic retinopathy, L-FABP, polymorphism
References
1.Balashevich LI, Izmailov AS. [Diabetic ophthalmopathy]. St. Petersburg: Chelovek; 2012. Russian.
2.Shilova OG. [New aspects of the pathogenesis and treatment of diabetic retinopathy]. International journal of endocrinology. 2012;4(44). Russian.
3.Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.
4.Mogilevskyy SIu , Bushuieva OV, Natrus OV. [Features of diabetic retinopathy in patients with diabetes mellitus 2 type]. Arkhiv Oftal'mologii Ukrainy. 2017;5(1):37-44. Ukrainian. DOI: https://doi.org/10.22141/2309-8147.5.1.2017.172575.
5.Chernobryvtsev O.P. The endothelial dysfunction factors in diabetes mellitus 2 type. F J Educ Health Sport. 2019; 9 (1) : 410-416; 10.5281/zenodo.2608956.
6.Benarous R, Sasongko MB, Qureshi S, et al. Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52(10):7464-9.
7.Cetin EN, Bulgu Y, Ozdemir S, et al. Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol. 2013;6(3):346-9.
8.Rema M, Srivastava BK, Anitha B, et al. Association of serum lipids with diabetic retinopathy in urban South Indians – the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med. 2006; 23(9):1029-36.
9.Grimaldi PA. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cell Mol Life Sci. 2007 Oct;64(19-20):2459-64.
10.Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl M-C, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000 Sep;26(1):76-80.
11.Petr M, Stastny P, Zajac A, et al. The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review. Int J Mol Sci. 2018 May 15;19(5):1472.
12.Esteves A, Ehrlich R. Invertebrate intracellular fatty acid binding proteins. Comp Biochem Physiol C Toxicol Pharmacol. Mar-Apr 2006;142(3-4):262-74.
13.Choromańska B, Myśliwiec P, Dadan J, Hady HR, Chabowski A. The clinical significance of fatty acid binding proteins. Postepy Hig Med Dosw (Online). 2011 Nov 24;65:759-63.
14.Natrus LV, Gayova LV, Byjhovets MYu, Osadchuk YuS, Konovalov SE. [The value of regulatory effects on lipid metabolism in complicated type 2 diabetes mellitus]. Phyziologichnyi zhurnal. 2020;66(1):25-34. Ukrainian.
15.Rykov SO, Bykhovets MIu, Natrus LV. [Influence of L-FABP expression and fatty-acid composition of food on the lipid metabolism in patients with different degree of diabetic retinopathy and diabetes mellitus type 2]. Arkhiv Oftal'mologii Ukrainy. 2019; 7(3):27-36. Ukrainian.
16.Rykov SO, Natrus LV, Bykhovets MIu. PPARγ-mediated differences in energy substrate among T2DM patients differing in the stage of diabetic retinopathy. J Оphthalmol (Ukraine). 2019;6:7-14.
17.Atshaves BP, Martin G, Hostetler HA, et al. Liver Fatty Acid Binding Protein and Obesity. J Nutr Biochem. 2010 Nov;21(11):1015-32.
18.Peng X, Wu Y, Zhu Y, Huang R. Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels. PLoS ONE. 2015 Oct 6;10(10):e0139417.
19.Wang Gu Qi, Bonkovsky HL, de Lemos A, Burczynski FJ. Recent insights into the biological functions of liver Fatty Acid Binding Protein 1. J Lipid Res. 2015 Dec;56(12):2238-47.
20.Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002 Feb 5;105(5):546-9.
21.Mogilevskyy SYu, Panchenko YuO, Ziablitsev SV, Natrus LV. [Disturbed platelet aggregation as a factor of diabetic maculopathy and diabetic macular edema in patients with nonproliferative diabetic retinopathy in type 2 diabetes mellitus]. Arkhiv Oftal'mologii Ukrainy. 2018; 6(3):26-31. Ukrainian.
22.Mokrii YaV, Ziablitsev SV. [Effect of Pro12Ala polymorphism of PPARG gene on lipid peroxidation and antioxidant defense in patients with type 2 diabetes depending on the duration of the disease]. Patologiia. 2016;2(37):52-7.
23.Shi J, Zhang Y, Gu W, Cui B, Xu M, Yan Q, et al. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. PLoS ONE. 2012;7(11): e48777.
24.Odegaard AO, Jacobs DR, Sanchez OA, et al. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016 Mar 24;15:51.
25.Su Y, Liu XM, Sun YM, Jin HB, Fu R, Wang YY, et al. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract. 2008 Jun;62(6):877-82.
The authors certify that they have no conflicts of interest in the subject matter or materials discussed in this manuscript.